🟢 Moderna is trading 12.41% up today after recovering from August 20’s 23.55% drop

Moderna is trading $149.86 (+12.41%) after recovering from the August 20 profit-taking decline.

• The decline was 23.55%, following the prior session’s 176.97% surge.
• That earlier rally followed positive Phase 3 melanoma-vaccine results with Merck, which met recurrence and metastasis-related goals.
• No new company-specific announcement was identified for August 21; biotech remained weaker overall.